Henley & Partners: A Growing Passport Divide Reshapes Global Mobility in 2026
LONDON, Jan. 13, 2026 /PRNewswire/ -- Marking two decades since its inception,…
Sharjah Achieves Historic WHO Age-Friendly Status
SHARJAH, UAE, Jan. 19, 2026 /PRNewswire/ -- The Emirate of Sharjah, UAE,…
SEON Launches Identity Verification Built on Real-Time Fraud Intelligence
LONDON and BARCELONA, Spain, Jan. 19, 2026 (GLOBE NEWSWIRE) -- SEON, the…
ASM pre-announces Q4 bookings and revenue ahead of expectations
Almere, The NetherlandsJanuary 19, 2026, 8:00 a.m. CET ASM International N.V. (Euronext…
Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom.
January 19, 2026 02:00 ET | Source: RIBER Riber receives a new…
Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation
Elliott, the largest independent shareholder of Toyota Industries, believes the revised tender…
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan.…
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan.…
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Company to host conference call and webcast on Tuesday, January 20, 2026…
NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients
NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS,…
